These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 222378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA, Viksler VK.
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [Abstract] [Full Text] [Related]

  • 4. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H, Yoshioka T, Shima J, Kosugi A, Itoh K, Hamaoka T.
    J Immunol; 1986 Apr 01; 136(7):2715-9. PubMed ID: 3005417
    [Abstract] [Full Text] [Related]

  • 5. [Cytotoxic antibodies in the serum of C3H mice after inoculating them with spontaneous mammary gland tumor cells].
    Lavrovskiĭ VA, Viksler VKh.
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep 01; (9):57-61. PubMed ID: 227196
    [Abstract] [Full Text] [Related]

  • 6. Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor.
    Blair PB, Lane MA, Mar P.
    J Immunol; 1976 Mar 01; 116(3):606-9. PubMed ID: 176266
    [Abstract] [Full Text] [Related]

  • 7. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L, Fuji H.
    Cancer Res; 1983 Jun 01; 43(6):2592-9. PubMed ID: 6342755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes.
    Seto M, Takahashi T, Nakamura S, Matsudaira Y, Nishizuka Y.
    Cancer Res; 1983 Oct 01; 43(10):4768-73. PubMed ID: 6192909
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
    Takahashi T, Seto M, Hara T.
    Gan To Kagaku Ryoho; 1983 Aug 01; 10(8):1894-1900. PubMed ID: 6882010
    [Abstract] [Full Text] [Related]

  • 14. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N, Tokura Y, Takigawa M, Egawa K.
    J Immunol; 1999 Jul 01; 163(1):242-9. PubMed ID: 10384122
    [Abstract] [Full Text] [Related]

  • 15. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.
    Hayashi T, Nakao K, Nagayama Y, Saitoh O, Ichikawa T, Ishikawa H, Hamasaki K, Eguchi K, Ishii N.
    Int J Oncol; 2005 May 01; 26(5):1313-9. PubMed ID: 15809723
    [Abstract] [Full Text] [Related]

  • 16. Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer.
    Lichtor T, Glick RP, Lin H, O-Sullivan I, Cohen EP.
    Cancer Gene Ther; 2005 Aug 01; 12(8):708-14. PubMed ID: 15803143
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of tumour and normal cells to the effect of immune lymphocytes in vitro and some properties of target cells determing this sensitivity.
    Lavrovsky VA, Razvorotnev VA.
    Folia Biol (Praha); 1976 Aug 01; 22(2):108-15. PubMed ID: 776718
    [Abstract] [Full Text] [Related]

  • 18. Role of apoptosis for mouse liver growth regulation and tumor promotion: comparative analysis of mice with high (C3H/He) and low (C57Bl/6J) cancer susceptibility.
    Bursch W, Grasl-Kraupp B, Wastl U, Hufnagl K, Chabicovsky M, Taper H, Schulte-Hermann R.
    Toxicol Lett; 2004 Apr 01; 149(1-3):25-35. PubMed ID: 15093245
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.